Observational studyLangenbeck's archives of surgery2026
Actual 10-year survival after total pancreatectomy: a multicenter study.
Observational study in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTotal pancreatectomy (TP) has attracted increasing attention because short-term outcomes have improved. However, long-term data remain limited. This study evaluated long-term outcomes after TP, focusing on actual 10-year survivors and causes of death.
methodsThis study included patients who underwent elective TP for pancreatic disease and were followed for at least 10 years or until death. Patients were classified as 10-year survivors or non-survivors. Clinicopathological characteristics, long-term survival, and causes of death were analyzed.
resultsForty-nine patients were included. Single-stage TP was performed in 30 patients (61.2%) and completion TP in 19 (38.8%). Pancreatic ductal adenocarcinoma accounted for 57.1% of indications for TP. R0 resection was achieved in 87.8% of patients, with no in-hospital mortality. The actual 5- and 10-year overall survival rates were 28.6% and 18.4%, respectively. Nine patients (18.4%) were actual 10-year survivors; none underwent vascular resection and reconstruction (p = 0.019), multivisceral resection (p = 0.322), or R1/2 resection (p = 0.577). One-third of the 10-year survivors had non-invasive intraductal papillary mucinous neoplasms (p = 0.016). In multivariate analysis, vascular resection and reconstruction was associated with worse overall survival (p = 0.016). Most deaths occurred within 5 years after TP and were mainly attributable to disease progression.
conclusionLong-term outcomes after TP appear to be influenced predominantly by oncological factors. Actual 10-year survivors were observed mainly among patients with benign or more favorable tumor characteristics who did not require extended resection. Given the heterogeneity of underlying diseases and surgical indications, these findings should be interpreted as primarily descriptive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.